Platelet counts were measured before and after red cell transfusions in 30 patients with anaemia and severe thrombocytopenia resulting from haematological diseases. There was a mean reduction of 1.1 x 109/l (P = 0.43) in the platelet count after transfusions of 2-3 units of leucocyte-depleted red cell concentrates (20 patients). However, there was a mean reduction of 2.7 x 109/l (P = 0.03), approximately 10%, in the platelet count after transfusions of non-leucocyte-depleted red cell concentrates (10 patients). The findings suggest that the forthcoming introduction of universal leucocyte depletion of red cell concentrates will minimize the worsening of thrombocytopenia that occurs in severely thrombocytopenic patients receiving standard non...
Aim: To present the number and adverse post-transfusion reactions with patients suffering from bone ...
The following are indications for platelet transfusion in leukemia, aplastic anemia, idiopathic thro...
The effectiveness of platelet transfusions, an essential supportive care for mostly hemato-oncologic...
Backgroud: The presence of leucocytes in blood components is cause for appearance of various adverse...
SUBJECT: In order to assess the impact of leukocyte reduction, all transfusion reactions reported at...
Introduction: The removal of the leucocites with the help of filtration improves the quality of red ...
To study survival and function of leukocyte-poor platelet concentrates (lp-PC) prepared from buffy c...
Blood components used in Niigata Universithy Hospital for the past 10 years were analyzed. Approxima...
According to current guidelines, patients with thrombocytopenia due to myelosuppression are supporte...
Background. The aim of this study was to evaluate the quality of red blood cell concentrates obtaine...
Development of permanent platelet refractoriness is a major problem in multitransfused patients with...
Purpose We report the use and effect of prophylactic platelet transfusions in critically ill thrombo...
We prospectively randomized 51 patients with haematological malignancy requiring platelet concentrat...
Randomized controlled trials have shown a reduction in platelet alloimmunization and refractoriness ...
International audienceObjectiveTo evaluate the impact of pathogen-reduced (PR) platelet transfusions...
Aim: To present the number and adverse post-transfusion reactions with patients suffering from bone ...
The following are indications for platelet transfusion in leukemia, aplastic anemia, idiopathic thro...
The effectiveness of platelet transfusions, an essential supportive care for mostly hemato-oncologic...
Backgroud: The presence of leucocytes in blood components is cause for appearance of various adverse...
SUBJECT: In order to assess the impact of leukocyte reduction, all transfusion reactions reported at...
Introduction: The removal of the leucocites with the help of filtration improves the quality of red ...
To study survival and function of leukocyte-poor platelet concentrates (lp-PC) prepared from buffy c...
Blood components used in Niigata Universithy Hospital for the past 10 years were analyzed. Approxima...
According to current guidelines, patients with thrombocytopenia due to myelosuppression are supporte...
Background. The aim of this study was to evaluate the quality of red blood cell concentrates obtaine...
Development of permanent platelet refractoriness is a major problem in multitransfused patients with...
Purpose We report the use and effect of prophylactic platelet transfusions in critically ill thrombo...
We prospectively randomized 51 patients with haematological malignancy requiring platelet concentrat...
Randomized controlled trials have shown a reduction in platelet alloimmunization and refractoriness ...
International audienceObjectiveTo evaluate the impact of pathogen-reduced (PR) platelet transfusions...
Aim: To present the number and adverse post-transfusion reactions with patients suffering from bone ...
The following are indications for platelet transfusion in leukemia, aplastic anemia, idiopathic thro...
The effectiveness of platelet transfusions, an essential supportive care for mostly hemato-oncologic...